Table 3 The characteristics of medications used to manage patients with T2DM and HTN in Hiwot Fana Specialized University Hospital, 2017 (n = 203)
Medication characteristics | n (%) |
|---|---|
DM medication | |
Metformin + glibenclamide | 78 (38.4) |
Metformin | 70 (34.5) |
Insulin + metformin | 21 (10.3) |
Insulin | 16 (7.9) |
Insulin + glibenclamide | 11 (5.4) |
Glibenclamide | 7 (3.4) |
Classes of HTN medication used | |
ACEIs | 41 (20.2) |
CCBs | 29 (14.3) |
Diuretics | 15 (7.4) |
Beta blockers | 4 (2.0) |
Centrally acting α2 agonist | 4 (2.0) |
Combined classes | 67 (33.0) |
ADR reported | |
Gastrointestinal upset | 36 (17.7) |
Dry cough | 24 (11.8) |
Hypoglycaemia | 7 (3.4) |
Ankle oedema | 2 (1.0) |